Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:39 AM UTC
| NCT Number | NCT06441890 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 28 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Illinois at Chicago |
| Last Updated on CT.gov | July 14, 2025 (Jul 14, 2025) |
As of July 17, 2026: Clinical trial NCT06441890 is currently recruiting participants. This phase2 study for breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Illinois at Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06441890 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06441890 was last updated Jul 14, 2025 (July 14, 2025). HelloStudys verifies this status automatically.